Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars-Olof Hattenbach

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Clinical Case Reports|February 10, 2023
Frosted branch angiitis as an immune recovery response in newly diagnosed acquired immunodeficiency syndrome and systemic cytomegalovirus infectionElisa Huynh, Argyrios Chronopoulos, James Scott Schutz, et al.
Case Reports in Ophthalmology|March 27, 2023
Isolated Internal Ophthalmoplegia from Posterior Cerebral Artery Neurovascular ConflictArgyrios Chronopoulos, Andrea Consigli, Julia Heim, et al.
European Journal of Ophthalmology|May 21, 2025
The effect of brolucizumab on diabetic macular edema and ischemia; a real-world analysisArgyrios Chronopoulos, Lourdes Vidal-Oliver, Lea K Sas, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 3, 2020
[Crisis management strategies of hospitals during the pandemic]Lars-Olof Hattenbach, Thomas Reinhard, Peter Walter, et al.
Acta Ophthalmologica|July 22, 2014
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trialAmelie Pielen, Alireza Mirshahi, Nicolas Feltgen, et al.
Retina (Philadelphia, Pa.)|July 9, 2009
Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusionLars-Olof Hattenbach, Carl Friedrich Arndt, Ralf Lerche, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 4, 2021
Impact of the SARS-CoV-2 pandemic on ophthalmic care in GermanyLars-Olof Hattenbach, Peter Heinz, Nicolas Feltgen, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 27, 2020
[Impacts of the SARS-CoV-2 pandemic on ophthalmic care in Germany]Lars-Olof Hattenbach, Peter Heinz, Nicolas Feltgen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 21, 2021
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMDRamin Khoramnia, Marta S Figueroa, Lars-Olof Hattenbach, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|April 23, 2004
Pigment epithelium endoscopic laser surgery for treatment of choroidal neovascularizationFrank H J Koch, Hugo Quiroz-Mercado, Lars-Olof Hattenbach, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Clinical Case Reports|February 10, 2023
Frosted branch angiitis as an immune recovery response in newly diagnosed acquired immunodeficiency syndrome and systemic cytomegalovirus infectionElisa Huynh, Argyrios Chronopoulos, James Scott Schutz, et al.
Case Reports in Ophthalmology|March 27, 2023
Isolated Internal Ophthalmoplegia from Posterior Cerebral Artery Neurovascular ConflictArgyrios Chronopoulos, Andrea Consigli, Julia Heim, et al.
European Journal of Ophthalmology|May 21, 2025
The effect of brolucizumab on diabetic macular edema and ischemia; a real-world analysisArgyrios Chronopoulos, Lourdes Vidal-Oliver, Lea K Sas, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 3, 2020
[Crisis management strategies of hospitals during the pandemic]Lars-Olof Hattenbach, Thomas Reinhard, Peter Walter, et al.
Acta Ophthalmologica|July 22, 2014
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trialAmelie Pielen, Alireza Mirshahi, Nicolas Feltgen, et al.
Retina (Philadelphia, Pa.)|July 9, 2009
Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusionLars-Olof Hattenbach, Carl Friedrich Arndt, Ralf Lerche, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 4, 2021
Impact of the SARS-CoV-2 pandemic on ophthalmic care in GermanyLars-Olof Hattenbach, Peter Heinz, Nicolas Feltgen, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 27, 2020
[Impacts of the SARS-CoV-2 pandemic on ophthalmic care in Germany]Lars-Olof Hattenbach, Peter Heinz, Nicolas Feltgen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 21, 2021
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMDRamin Khoramnia, Marta S Figueroa, Lars-Olof Hattenbach, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|April 23, 2004
Pigment epithelium endoscopic laser surgery for treatment of choroidal neovascularizationFrank H J Koch, Hugo Quiroz-Mercado, Lars-Olof Hattenbach, et al.
Pageof 9